TAG:
pathology groups
Oncology’s Potential Drives AP Lab Expansion
CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are …
Pathology Consultants See In-House AP Trend Unfolding
LOCAL PATHOLOGY GROUP PRACTICES are themselves the “canary in the coal mine” to provide early warning about the exploding interest of specialist physicians at capturing the anatomic pathology (AP) revenues generated by their patients. THE DARK REPORT interviewed three consultants, each of whom s…
Linking UroCor Indictments With Specialist Doc Pathology
IS THE TIMING of the criminal indictments of three ex-UroCor executives going to be a fortuitous event for the anatomic pathology profession? I ask this question because the exploding trend of specialist physician groups internalizing anatomic pathology services was slated to be the…
National AP Firms Target Gastroenterology Groups
CEO SUMMARY: It’s a trend as yet invisible to the radar screens of most pathology groups. A new crop of specialty AP companies is targeting gastroenterology. In the past 36 months, several have posted phenomenal growth in both specimen volume and revenue. The heightened competition for …
Digene, Kaiser Northern California, ARUP Labs, Bio-Reference Labs, Specialty Labs
DIGENE ENJOYS GROWTH OF 39% IN RECENT MONTHS FUELED BY RECOGNITION that HPV plays a key role in causing cervical cancer, demand for Digene Corporation’s hc2 High-Risk HPV DNA test is increasing at impressive rates. For fiscal third quarter 2004, Digene reported revenue gr…
CalPERS Drops 38 Hospitals From Its Preferred Network
IF CALPERS HAS ITS WAY, 38 hospitals and 17 physician groups will no longer be able to provide services to its healthcare network. On May 19, 2004, the California Public Employees’ Retirement System (CalPERS) announced a list of providers that it was excluding from its provider n…
Pathologist Activities Evolve In VA’s “Paperless” Hospitals
“When a hospital or laboratory goes ‘paperless’, it’s no longer ‘business as usual’ for pathologists.” —Bruce Dunn, M.D. CEO SUMMARY: One outcome of the Veteran Administration’s (VA) ongoing effort to create a totally-integrated i…
Health Line Clinical Labs, ChromaVision, Cytyc, TriPath, Quest Diagnostics
HEALTH LINE CLINICAL LABS SIGNS $10 MILLION FRAUD SETTLEMENT WITH FEDS DESPITE THE EVIDENCE that packing unnecessary tests into test panels is not acceptable to Medicare and Medicaid authorities, some laboratories continue the practice. Health Line Clinical Laboratories, Inc…
AmeriPath Reports on 2003, Its First Year as a Private Firm
WILL BUSINESS BE BETTER for AmeriPath, Inc. as a private company than it was as a publicly-traded firm? Its 2003 financial report indicates some interesting challenges, many common to all laboratories. First, a look at basic numbers. AmeriPath’s net revenues grew from $478.8 milli…
Oncology Diagnostics Attracts Big Money
MORE SURPRISING DEVELOPMENTS for the anatomic pathology profession during the past three weeks! The impending $215 million acquisition of IMPATH, Inc. by Genzyme Corporation, announced on March 1, has the …
CURRENT ISSUE
Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.